Effects of incentives on treatment rates among young people with rheumatic fever in Waikato, New Zealand

Not Applicable

Completed

• Conditions: Rheumatic fever; Cardiovascular - Other cardiovascular diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12618001150235
• Lead Sponsor: John Oetzel

Brief Summary

Background: Acute rheumatic fever in New Zealand persists and is a barometer of equity as its burden almost exclusively falls on Maori and Pacific Island populations. The primary objective of this study was to determine whether an incentive programme resulted in increased secondary prophylaxis injections over a one-year period compared to a baseline period prior to the intervention. Methods: The evaluation used a multiple baseline study to determine whether an incentive consisting of a mobile phone and monthly “top-up” (for data/calls) resulted in increased injections, increased texts/calls with nurses, reduced number of visits to get a successful injection, less medicine wasted, and increased nurse satisfaction. Participants were 77 young people (aged 14-21) on an acute rheumatic fever registry in Waikato region, New Zealand classified as either fully adherent (all injections received and no more than one late) or partially adherent based on injections at baseline. Results: There was a sharp increase in injections for intermittent patients post-intervention and then a slight decrease overtime, while fully adherent patients maintained their high rate of injections. A similar pattern for nurse satisfaction emerged. The number of calls/texts increased for all patients. The number of visits went down for partially adherent patients and up for fully adherent patients.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2017-10-31
• Study Start: 2018-07-12
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Registered patient on the Waikato District Health Board 's registry for patients with rheumatic fever

Exclusion Criteria

None other than age

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Injection--whether it was received or not; Recorded by a district nurse shortly after the scheduled injection date (target: within one week). This information was reported onto a data collection form for this study and entered into the patients medical records.[Measured every 28 days for 15 months]